Vivo Capital Closes $750M Sino-US Healthcare Fund

Login to View

Sino-U.S. healthcare investment firm Vivo Capital has reached final closing of its eighth fund, Vivo Capital Fund VIII L.P., at US$750 million, according to a company announcement.

With offices in Palo Alto, California, as well as in Beijing and Shanghai in China, Vivo Capital says the latest closing will bring the firm’s total assets-under-management to over US$1.7 billion.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in